Searched for
LUPIN S PITHAMPUR
Lupin gets USFDA nod for generic smoking cessation treatment tabletsPharma major Lupin Ltd on Wednesday said it has received approval from the US health regulator to market its generic Varenicline tablets in...- Lupin gets USFDA nod to market generic antifungal tabletsThe approval granted by the US Food and Drug Administration (USFDA) for the abbreviated new drug application of Fluconazole tablets in stre...
- Lupin gets USFDA nod for Bromfenac Ophthalmic SolutionPharma major Lupin on Wednesday said it has received approval from the US health regulator to market its generic Bromfenac Ophthalmic Solut...
- Lupin gets EIR for Pithampur Unit-2, paves way for resolving warning letterThe EIR represents the closure of the inspection, and also paves the way for possible lifting of warning letters on the facility imposed by...
- Lupin recalls 4,113 cartons of oral contraceptive medicine in US marketThe company is recalling the lot due to it being "Subpotent Drug", the US health regulator noted in the report.
- Plan to approach USFDA for re-inspection of key plants in next few months: LupinThe US drug regulator, after inspecting the two sites, had expressed concerns over quality-control procedures that include handling of out-...
- Sell Lupin, target Rs 800: Elara CapitalSell Lupin at a price target of Rs 800.
- Lupin shares fall 3% as USFDA warns of regulatory actionUSFDA warned the firm that it may withhold approval of any pending applications or supplements in which this facility is listed.
- Lupin's Pithampur unit gets inspection closure report from USFDAPithampur Unit-3 facility is involved in the manufacture of metered dose inhalers.
- Lupin gets 6 observations from USFDA for its Pithampur Unit-2The inspection of Pithampur Unit -2 was carried out by the United States Food and Drug administration (USFDA) between January 14 and Januar...
- Lupin gets EIR from USFDA for Pithampur facility unitLupin's Pithampur facility manufactures dermatological products, dry product inhalers, and metered dose inhalers.
- Lupin gets EIR from USFDA for Pithampur facilityIn November last, Lupin had received warning letter from USFDA (US Food and Drug Administration) for its manufacturing facilities in Goa an...
- Lupin's Pithampur unit gets Health Canada clearanceIn November 2017, Lupin had received warning letter from US Food and Drug Administration for its manufacturing facilities in Goa and Pitham...
- USFDA issues warning letter to Lupin's Goa, Indore plantsOn Lupin's Pithampur (Indore) plant, the US health regulator said the company invalidated initial OOS laboratory results without adequate i...
- Lupin gets warning letter from USFDA for Goa, Indore unitsThe company upholds quality and compliance issues with utmost seriousness and remains fully committed to be compliant with cGMP quality sta...
- Things should normalise for pharma sector from FY20-21: S Ramesh, Lupin"There is a fresh wave of consolidation expected next year that could trigger another wave of price erosion."
- Lupin's Aurangabad plant undergoes USFDA inspectionLast week, Unit 1 of Lupin's Pithampur facility had successfully undergone inspection on good manufacturing practice (GMP) as well as PAI b...
- Lupin recalls 12,480 bottles of anti-depressant drug from USLupin Pharmaceuticals Inc is recalling 12,480 bottles of Paroxetine extended-release tablets in the strength of 12.5 mg manufactured by Lup...
- Lupin launches generic conjunctivitis treatment medicine in USThe product is produced at Lupin's Pithampur manufacturing facility, it added. The medicine is generic equivalent of Novartis Corp's Vigamo...
- Lupin tanks to 3-year lows on USFDA observationsThere are no appropriate control procedures established over computers or related systems,USFDA observed.
Load More
